| An expanded universe of cancer targets WC Hahn, JS Bader, TP Braun, A Califano, PA Clemons, BJ Druker, ... Cell 184 (5), 1142-1155, 2021 | 157 | 2021 |
| A recellularized human colon model identifies cancer driver genes HJ Chen, Z Wei, J Sun, A Bhattacharya, DJ Savage, R Serda, Y Mackeyev, ... Nature biotechnology 34 (8), 845-851, 2016 | 98 | 2016 |
| Endoplasmic reticulum quality control in cancer: Friend or foe H Kim, A Bhattacharya, L Qi Seminars in cancer biology 33, 25-33, 2015 | 85 | 2015 |
| ER-associated degradation in health and disease–from substrate to organism A Bhattacharya, L Qi Journal of Cell Science 132 (23), jcs232850, 2019 | 75 | 2019 |
| Hepatic Sel1L‐Hrd1 ER‐associated degradation (ERAD) manages FGF21 levels and systemic metabolism via CREBH A Bhattacharya, S Sun, H Wang, M Liu, Q Long, L Yin, S Kersten, K Zhang, ... The EMBO journal 37 (22), e99277, 2018 | 66 | 2018 |
| Feeding Angptl4−/− mice trans fat promotes foam cell formation in mesenteric lymph nodes without leading to ascites [S] AB Oteng, A Bhattacharya, S Brodesser, L Qi, NS Tan, S Kersten Journal of lipid research 58 (6), 1100-1113, 2017 | 35 | 2017 |
| Hepatic SEL1L-HRD1 ER-associated degradation regulates systemic iron homeostasis via ceruloplasmin P Thepsuwan, A Bhattacharya, Z Song, S Hippleheuser, S Feng, X Wei, ... Proceedings of the National Academy of Sciences 120 (2), e2212644120, 2023 | 8 | 2023 |
| SEL1L-HRD1 ER-associated degradation suppresses hepatocyte hyperproliferation and liver cancer A Bhattacharya, J Wei, W Song, B Gao, C Tian, SA Wu, J Wang, L Chen, ... Iscience 25 (10), 2022 | 8 | 2022 |
| A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum DL Gillen, FL Meyskens, TR Morgan, JA Zell, R Carroll, R Benya, ... Cancer Prevention Research 8 (3), 222-230, 2015 | 3 | 2015 |
| Endoplasmic reticulum associated degradation (ERAD) in the liver A Bhattacharya | 1 | 2019 |
| Author Correction: A recellularized human colon model identifies cancer driver genes (Nature Biotechnology,(2016), 34, 8,(845-851), 10.1038/nbt. 3586) HJ Chen, Z Wei, J Sun, A Bhattacharya, DJ Savage, R Serda, Y Mackeyev, ... Nature biotechnology 37 (7), 820, 2019 | 1 | 2019 |
| New perspectives on ERAD in health and disease: from organism to cell A Bhattacharya ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION (ERAD) IN THE LIVER, 2, 2019 | | 2019 |
| Sel1L-Hrd1 ERAD suppresses liver cancer via the Wnt signaling pathway A Bhattacharya, D Thomas, L Chen, L Qi ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION (ERAD) IN THE LIVER, 123, 2019 | | 2019 |
| Hepatic Sel1L-Hrd1 ERAD regulates bile homeostasis via bile exporter proteins A Bhattacharya, G Kakiyama, H Takei, H Nittono, L Qi ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION (ERAD) IN THE LIVER, 68, 2019 | | 2019 |
| A recellularized human colon model identifies cancer driver genes (vol 34, pg 845, 2016) HJ Chen, Z Wei, J Sun, A Bhattacharya, DJ Savage, R Serda, Y Mackeyev, ... NATURE BIOTECHNOLOGY 37 (7), 820-820, 2019 | | 2019 |
| Hepatic Endoplasmic Reticulum Associated Degradation (ERAD) manages FGF21 levels and metabolism via CREBH during fasting‐feeding and growth A Bhattacharya, K Zhang, L Qi The FASEB Journal 32, 653.2-653.2, 2018 | | 2018 |
| Levy, AV, 359 S Akella, VS Avduevsky, A Bhattacharya, MA Bronovets, IA Buyanovsky, ... Wear 136 (385), 385, 1990 | | 1990 |
